Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

5772 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
67-1   / INO Therapeutics LLC Original drug sold in China Original drug imported to China The 67th Batch of Reference Listed Drugs
67-2   INOmax INO Therapeutics LLC Original drug not imported to China US Orange Book The 67th Batch of Reference Listed Drugs
67-3   CHEMET RECORDATI RARE DISEASES INC Original drug not imported to China US Orange Book The 67th Batch of Reference Listed Drugs
67-4   ISOLYTE S PH 7.4 IN PLASTIC CONTAINER B Braun Medical Inc Original drug not imported to China US Orange Book The 67th Batch of Reference Listed Drugs
67-5   XACIATO DARE BIOSCIENCE INC Original drug not imported to China US Orange Book The 67th Batch of Reference Listed Drugs
67-6   DETECTNET RADIOMEDIX INC Original drug not imported to China US Orange Book The 67th Batch of Reference Listed Drugs
67-7   NEPHROSCAN Theragnostics Inc. Original drug not imported to China US Orange Book The 67th Batch of Reference Listed Drugs
67-8   GLYCOPHOS Fresenius Kabi Nederland B.V. Original drug not imported to China Sold in the EU The 67th Batch of Reference Listed Drugs
67-9   Triderm Cream Merck Sharp & Dohme D.O.O. Original drug not imported to China Sold in the EU The 67th Batch of Reference Listed Drugs
67-10 ノルバスク(Norvasc) Viatris Inc. (ヴィアトリス製薬株式会社) Original drug not imported to China Sold in Japan The 67th Batch of Reference Listed Drugs